Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 12 Apr 2017  |  Global  |  Technology Research

    Therapeutic Breakthroughs in Alzheimer’s and Parkinson’s Diseases

    Disease-Modifying Treatments Likely to Transform the Clinical Management of Alzheimer’s and Parkinson’s Diseases

    The research service primarily encompasses comprehensive analyses of key emerging therapies across AD and PD.The service includes treatment overviews, emerging therapeutic platforms, IP and funding analysis, and emerging innovation profiles across Alzheimer's and Parkinson's diseases. Furthermore, the research service features the impact of key t...

    $4,950.00
  2. 24 Mar 2017  |  Asia Pacific  |  Market Research

    Digital and Computed Radiography in Thailand, Indonesia, and Malaysia, Forecast to 2021

    With Heavy Competition and Demand, Business Models are Transitioning to Value-based Solutions

    The study aims to analyze and forecast the digital and computed radiography market in Thailand, Indonesia, and Malaysia. Research Scope Market trends (penetration of DR and CR, future prospects, company profile, competitive structure; market metrics; market share; revenues; strategy) Regional trends (Thailand, Indonesia, and Malaysia) Analyses ...

    $1,500.00
  3. 23 Mar 2017  |  Asia Pacific  |  Market Research

    APAC Molecular Diagnostics Market, Forecast to 2021

    Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

    The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

    $4,950.00
  4. 16 Mar 2017  |  Global  |  Market Research

    Frost & Sullivan’s Top Emerging Markets List 2017

    Growth, Innovation and Leadership (GIL) Index for Emerging Markets

    The opening up of emerging markets to global capital, technology, and talent over the past two decades has fundamentally changed their economic and business environment. Rapid emerging market economic growth has helped lift millions out of poverty and expand the middle class, creating new markets for consumer products and services. In addition a la...

    $1,500.00
  5. 02 Mar 2017  |  Global  |  Technology Research

    Biomarkers Enabling Diabetes and Obesity Management

    Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

    Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

    $4,950.00
  6. 24 Jan 2017  |  Asia Pacific  |  Market Research

    Game-changing Strategies of APAC Pharma Companies

    Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

    $1,500.00
  7. $1,500.00
  8. 12 Jan 2017  |  Global  |  Market Research

    Future of Behavioral Healthcare Paradigms, Forecast to 2022

    Digital Solutions to Address Challenges in Patient Engagement and Support

    The annual global cost of mental illnesses is set to rise to a whopping $6 trillion in 2030, from $2.5 trillion in 2010. Furthermore, the global treatment gap in 2004 for disorders such as depression and anxiety was more than 50% (half of the patients went untreated). Unfortunately, the situation has still not changed significantly. A growing body...

    $4,950.00
  9. 29 Dec 2014  |  Global  |  Technology Research

    Emerging Trends in Cell Banking (Technical Insights)

    Trends in Master and Working Cell Baking

    The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in ...

    $3,950.00
  10. 26 Dec 2014  |  Global  |  Technology Research

    Advances in Biosensing Technologies (Technical Insights)

    This research service summarises the developments occuring in the biosensing industry.

    $3,950.00